Supernus Pharmaceuticals Inc (SUPN) revenue is $192.1M
Supernus Pharmaceuticals Inc (SUPN) revenue is $192.1M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full SUPN research page for quote, filings, and the rest of the model. This satellite exists so “Supernus Pharmaceuticals Inc revenue” can rank with the actual number, then send you to /stock/supn.